🟢 Adaptive Biotechnologies is trading 4.67% up in pre-market; no clear catalyst identified

Adaptive Biotechnologies is trading at $26.70, up 4.67% in pre-market; the reason for the gain remains unclear.

• No clear company-specific announcement or overnight catalyst explaining the pre-market move was identified.
• The next scheduled company event is third-quarter results on November 4, not an announcement from October 26.
• Major U.S. indices are modestly higher, but none has reached the 0.5% threshold for attributing the move to broad-market sentiment; pre-market volume or activity details were unavailable.